Not directly. Insurance typically covers TMS under a Major Depressive Disorder (MDD) diagnosis. If symptoms qualify as MDD, coverage may apply. We help navigate this process.
Yes. We often pair qpTMS™ with qEEG, neurofeedback, and PnIR—all of which are safe, non-invasive therapies for pregnant patients.
Yes. While focused on depression, qpTMS™ can also regulate brain regions involved in anxiety, offering broader emotional support.
Most patients complete 30–40 sessions over 6–8 weeks. Treatment is customized and progress is monitored closely.
